{"entity":{"id":"nct06810804","kind":"trial","name":"A Phase IIa Study to Evaluate NBQ72S","aka":[],"tldr":"A phase 2 trial of NBQ72S in advanced solid tumours, run by Nantong Bencao Quadriga Medical Technology Co. Ltd., now recruiting.","summary":"A Phase IIa Study to Evaluate NBQ72S is a phase 2 interventional study registered as NCT06810804 by Nantong Bencao Quadriga Medical Technology Co. Ltd., with 10 participants planned, started 2025-04-22 and due to reach its primary completion in 2026-08-31. Interventions recorded: NBQ72S.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06810804","url":"https://clinicaltrials.gov/study/NCT06810804"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06810804","phase":"2","setting":"A Phase IIa Study to Evaluate the Efficacy and Safety of NBQ72S in Breast Cancer Patients With Leptomeningeal Metastases, With or Without Brain Parenchymal Metastases","sponsor":"Nantong Bencao Quadriga Medical Technology Co. Ltd.","enrolled":10,"outcomes":[]},"route":"/trials/nct06810804/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}]}}